Updates

REMINDER: REBATE RULE WOULD DO NOTHING TO LOWER DRUG PRICES WHILE HIKING PREMIUMS ON SENIORS AND COSTING TAXPAYERS $200 BILLION

Nov 16, 2020

Administration Should Abandon Misguided Policy That Rewards Drug Companies’ Read More

CSRXP: COVID-19 TREATMENTS AND VACCINES MUST BE ACCESSIBLE AND AFFORDABLE FOR ALL AMERICANS

Nov 9, 2020

Pfizer Releases Positive Preliminary Data on Vaccine, Must Commit to Read More

BIG PHARMA EARNINGS WATCH: ABBVIE, ASTRAZENECA & BRISTOL-MYERS SQUIBB

Nov 5, 2020

Big Pharma Completes Sweep of Beating Wall Street Expectations After 2020 Read More

BIG PHARMA EARNINGS WATCH: AMGEN & SANOFI

Nov 5, 2020

Big Pharma Giant Sees Profits Jump After July Price Hikes Big Pharma giants Read More

CSRXP: GILEAD’S PRICE-GOUGING AMERICAN PUBLIC ON COVID-19 TREATMENT TAXPAYERS PAID TO DEVELOP

Oct 30, 2020

Big Pharma Company Reaping Profit Margin Higher Than 90 Percent on Remdesivir Read More

BIG PHARMA EARNINGS WATCH: GLAXOSMITHKLINE

Oct 29, 2020

Brand Name Big Pharma Giant Surpasses Expectations After Hiking Prices A new Read More

BIG PHARMA EARNINGS WATCH: MERCK, NOVARTIS & PFIZER

Oct 28, 2020

Brand Name Drug Companies Beat Wall Street Expectations After Repeatedly Read More

ICYMI: BIG PHARMA’S PANDEMIC PRICE HIKES AND PATENT ABUSE UNDERSCORE URGENCY FOR ACTION

Oct 28, 2020

Big Pharma’s Pandemic Price Hikes and Patent Abuse Underscore Urgency for Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Oct 13, 2020

Price Hikes Fuel Q3 Earnings Beat For Brand Name Giant As millions of Read More

CSRXP: PRESIDENTIAL CAMPAIGNS MUST BACK BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE

Oct 13, 2020

Surrogates for the 2020 Candidates Should Demonstrate Commitment To Lowering Read More

SECOND OPINION: PHARMA-BACKED REBATE RULE WOULD INCREASE OOP COSTS AND PREMIUMS FOR SENIORS — DO NOTHING TO LOWER RX PRICES

Oct 5, 2020

Big Pharma Claims Misguided Proposal Would Benefit Patients, Facts Show It Read More